Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men

Circulation

Volumn 102, Issue 17, 2000, Pages 2058-2062

  Zito, Francesco ^a   Drummond, Felicity ^a   Bujac, Sarah R ^b,c   Esnouf, M Peter ^d   Morrissey, James H ^b,e   Humphries, Steve E ^a   Miller, George J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Coagulation; Coronary disease; Epidemiology; Genes

Indexed keywords

BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 7; FIBRINOPEPTIDE A;

ADULT; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034711163     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.17.2058     Document Type: Article

References (35)

1. The contact phase of blood coagulation
2. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins)
3. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate
4. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells
5. The binding of high molecular weight kininogen to cultured human endothelial cells
6. Human blood coagulation factor XI: Purification, properties, and mechanism of activation by activated factor XII
7. Hageman factor substrates: Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis
8. Human high molecular weight kininogen: Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma
9. Kallikrein and plasmin as activators of inactive renin
10. Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid
11. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin 6 and neutrophil elastase
12. A comparison of the abilities of plasma kallikrein, β-factor XIIa, factor XIa, and urokinase to activate plasminogen
13. The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI)
14. Activation of human factor VII in plasma and in purified systems: Roles of activated factor IX, kallikrein and activated factor XII
15. Augmented Hageman factor and prolactin titers, enhanced cold activation of factor VII, and spontaneous shortening of prothrombin time in survivors of myocardial infarction
16. Hageman factor and risk of myocardial infarction in middle-aged men
17. Levels of activated FXII in survivors of myocardial infarction: Association with circulating risk factors and extent of coronary artery disease
18. Risk of coronary heart disease and activation of factor XII in middle-aged men
19. A common genetic polymorphism (46C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level
20. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men
21. 1+2 measurements
22. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bioassay to activated factor VII: An international study
23. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
24. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
25. 1+2 fragment and thrombin-antithrombin complex
26. A monoclonal antibody raised against human β-factor XIIa which also recognises α-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor
27. A simple salting out procedure for extracting DNA from human nucleated cells
28. Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose
29. FXII (46C→T) polymorphism and in vivo generation of FXII activity
30. Factor VIIa in patients with C1-inhibitor deficiency
31. In vivo bypass of hemophilia A coagulation defect by factor XIIa implant
32. Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction
33. Measurement of activated factor XII in health and disease